The peer-reviewed publication Metallomics supports the mechanism of action of Alterity’s neurological drug candidate Respiri ...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes ...

Ex-Rio and Arcelor Mittal executive Paul Berend says mainstream analysts have it wrong on iron ore’s future Now head of ...

Dengue fever is spreading to cooler climates and geographies such as California Attempts to develop treatments have been ...

ASX rises as tech and mining stocks rally. Meanwhile Nvidia overtakes Apple and the US election results are trickling in.

Speaking with Stockhead, Alkane Resources (ASX:ALK) boss Nic Earner lays down the case for self-sufficient exploration to ...

ASX medical imaging companies are capitalising on lucrative market of caring for US veterans with their innovative ...

Stockhead’s Sarah Hughan sits down with Tesoro Gold (ASX:TSO) managing director Zeff Reeves to get the short end of the long ...

Aussie shares slipped into the red on Tuesday, falling 0.4% as sentiment remained subdued after the Reserve Bank of Australia ...

When it comes to investing, Australians have long had a hard time looking past homegrown companies. And after a bumper year ...

The AGM season is shaping up as a nervous time for a bevy of life science companies facing a ‘second strike’ motion that ...

‘Fully funded’ is a phrase every explorer wants to announce to the market along the journey to prove up a resource and BMG – ...